This PTX-loaded nano drug delivery system demonstrates enhanced treatment efficacy in colorectal tumor-bearing mice and, furthermore, modulates the tumor immune microenvironment, including increased activation of CD4+ and CD8+ T cells, M1 macrophage polarization, and Treg cell downregulation. The gene discussed is CD4; the disease is colorectal neoplasm.